XML 80 R14.htm IDEA: XBRL DOCUMENT v3.25.3
Debt
 9 Months Ended
Sep. 30, 2025
Debt Disclosure [Abstract]  
Debt Disclosure DEBT
The following table summarizes the components of Long-term borrowings and finance lease obligations:
(in millions)September 30,
2025		December 31, 2024
2022 Credit Agreement (a)
$211.6 $210.9 
Finance lease obligations1.6 12.9 
Total long-term borrowings and finance lease obligations, including current portion213.2 223.8 
Less: Current maturities10.9 7.0 
Less: Current finance lease obligations1.1 12.4 
Total long-term borrowings and finance lease obligations$201.2 $204.4 
(a)     Defined as the Third Amended and Restated Credit Agreement, dated October 21, 2022, as amended.
As more fully described within Note 13 – Fair Value Measurements, the Company uses a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. The fair value of the Company’s long-term borrowings and finance lease obligations is based on interest rates that we believe are currently available to us for issuance of debt with similar terms and remaining maturities (Level 2 input). The carrying amounts of the Company’s long-term borrowings and finance lease obligations approximate their fair values as of September 30, 2025 and December 31, 2024.
The 2022 Credit Agreement was a senior secured credit facility that provided the Company and certain of its foreign subsidiaries access to an aggregate original principal amount of up to $800 million, consisting of (i) a revolving credit facility in an amount up to $675 million (the “2022 Revolver”) and (ii) a term loan facility in an original amount of up to $125 million. On May 16, 2024, the Company entered into the First Amendment to the 2022 Credit Agreement. The amendment was largely administrative in nature, including certain language to address ongoing reference rate reform. There were no changes to the term or the Company’s borrowing capacity under the 2022 Credit Agreement. The 2022 Credit Agreement was set to mature on October 21, 2027.
Borrowings under the 2022 Credit Agreement bore interest, at the Company’s option, at a base rate or an Adjusted Eurocurrency Rate (as defined in the 2022 Credit Agreement) in the case of borrowings in euros or an adjusted RFR (as defined in the 2022 Credit Agreement) in the case of borrowings in U.S. dollars, Canadian dollars, or British pounds, plus, in each case, an applicable margin. The applicable margin ranged from zero to 0.75% for base rate borrowings and 1.00% to 1.75% for Adjusted Eurocurrency Rate and RFR borrowings. The Company was also required to pay a commitment fee to the lenders ranging between 0.10% to 0.25% per annum on the unused portion of the 2022 Revolver along with other standard fees. Applicable margin, issuance fees, and other customary expenses were payable on outstanding letters of credit.
The Company was subject to certain net leverage ratio and interest coverage ratio financial covenants under the 2022 Credit Agreement that are measured at each fiscal quarter-end. The Company was in compliance with all such covenants as of September 30, 2025.
As of September 30, 2025, there was $94.4 million of cash drawn on the 2022 Revolver, $117.2 million outstanding under the term loan facility, and $10.9 million of undrawn letters of credit under the 2022 Credit Agreement, with $569.7 million of net availability for borrowings. As of December 31, 2024, there was $90.6 million of cash drawn on the 2022 Revolver, $120.3 million outstanding under the term loan facility, and $10.1 million of undrawn letters of credit under the 2022 Credit Agreement, with $574.3 million of net availability for borrowings.
The following table summarizes the gross borrowings and gross payments under the Company’s revolving credit facilities:
Nine Months Ended
September 30,
(in millions)20252024
Gross borrowings$99.4 $18.0 
Gross payments 98.3 82.4 
On October 29, 2025, the Company entered into the Fourth Amended and Restated Credit Agreement (the “2025 Credit
Agreement”), by and among the Company and certain of its foreign subsidiaries (collectively, the “Borrowers”), Wells Fargo
Bank, National Association, as administrative agent, swingline lender, and an issuing lender, BofA Securities, Inc., PNC Capital Markets LLC, Truist Bank, and U.S. Bank National Association as syndication agents, and the other lenders and parties
signatory thereto. The 2025 Credit Agreement amends and restates the 2022 Credit Agreement. See Note 14 – Subsequent Events for additional information.
Interest Rate Swaps
On October 21, 2022, the Company entered into an interest rate swap (the “2022 Swap”) with a notional amount of $75.0 million, as a means of fixing the floating interest rate component on $75.0 million of its variable-rate debt. The 2022 Swap is designated as a cash flow hedge, with an original maturity date of October 31, 2025.
On July 11, 2023, the Company entered into an additional interest rate swap (the “2023 Swap”) with a notional amount of $75.0 million, as a means of fixing the floating interest rate component on $75.0 million of its variable-rate debt. The 2023 Swap, which was designated as a cash flow hedge, matured on August 1, 2025.
As a result of the application of hedge accounting treatment, all unrealized gains and losses related to the derivative instruments are recorded in Accumulated other comprehensive loss and are reclassified into the Condensed Consolidated Statements of Operations as a component of Interest expense, net in the same period in which the hedged transaction affects earnings. Hedge effectiveness is assessed quarterly. The Company does not use derivative instruments for trading or speculative purposes.
The fair value of the Company’s interest rate swaps is derived from a discounted cash flow analysis based on the terms of the contract and the interest rate curve (Level 2 inputs) and measured on a recurring basis in our Condensed Consolidated Balance Sheets.
The fair value of the Company’s interest rate swaps was not significant at September 30, 2025 and was $0.3 million at December 31, 2024, and was included in Other current liabilities on the Condensed Consolidated Balance Sheets. During the three months ended September 30, 2025, unrealized pre-tax gains recorded in Accumulated other comprehensive loss were not significant. During the nine months ended September 30, 2025, unrealized pre-tax gains of $0.2 million were recorded in Accumulated other comprehensive loss. During the three and nine months ended September 30, 2024, unrealized pre-tax losses of $1.7 million and $0.3 million, respectively, were recorded in Accumulated other comprehensive loss. No ineffectiveness was recorded in either period.
In connection with entering into the 2022 Credit Agreement in October 2022, the Company terminated an interest rate swap initially entered into in 2019, receiving proceeds of $4.3 million upon settlement. The settlement gain was recorded in Accumulated other comprehensive loss and was amortized into earnings ratably through the original maturity date of July 30, 2024. During the three and nine months ended September 30, 2024, the Company recognized non-cash settlement gains of $0.2 million and $1.4 million, respectively, as a component of Interest expense, net on the Condensed Consolidated Statements of Operations.
Finance Leases
In the fourth quarter of 2024, the Company provided notice to the lessor of one of its leased U.S. manufacturing facilities of its intent to exercise the $11.5 million purchase option included in the lease agreement. The Company remeasured the corresponding lease liability, adjusted the right-of-use (“ROU”) asset, and reassessed the lease classification, resulting in a change in classification from an operating lease to a finance lease in the fourth quarter of 2024. The purchase was completed on February 10, 2025. As of the purchase date, the related finance lease ROU asset, net, was approximately $11.3 million and the finance lease liability was $11.5 million. The cash outflow of approximately $11.5 million related to the facility purchase is reflected as a component of Other, net within the financing activities on the Condensed Consolidated Statement of Cash Flows for the nine months ended September 30, 2025.
The following table summarizes the supplemental noncash investing and financing activities related to this facility purchase:
Nine Months Ended
September 30,
(in millions)2025
Purchase of properties and equipment through exchange of lease ROU asset$11.3 
Derecognition of ROU asset (11.3)